Previous studies comparing paclitaxel-eluting stents with stents eluting rapamycin ( now called sirolimus ) or its analogues ( everolimus or zotarolimus ) have produced contradictory results , ranging from equivalence between stent types to superiority of everolimus-eluting stents .